Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/11575
Title: | Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests. | Austin Authors: | Bahar-Fuchs, Alex;Villemagne, Victor L ;Ong, Kevin;Chetélat, Gaël;Lamb, Fiona ;Reininger, Cornelia B;Woodward, Michael M ;Rowe, Christopher C | Affiliation: | alex.baharfuchs@anu.edu.au Department of Nuclear Medicine, Centre for PET, Austin Health, Heidelberg, Victoria, Australia, Australia |
Issue Date: | 2013 | Publication information: | Journal of Alzheimer's Disease : Jad; 33(2): 451-62 | Abstract: | Assessment of disease biomarkers, particularly the in vivo assessment of amyloid-β (Aβ) burden with positron emission tomography (PET), is gradually becoming central to the diagnosis of mild cognitive impairment (MCI) due to Alzheimer's disease (AD). However, the incorporation of biomarker evidence to the diagnostic process is currently restricted mainly to research settings. The identification of memory measures that are associated with Aβ is of clinical relevance as this may enhance the confidence in making a diagnosis of MCI due to AD in clinical settings. Forty one persons with amnestic MCI underwent Aβ imaging with (18)F-Florbetaben PET, magnetic resonance imaging, and a comprehensive neuropsychological assessment. All measures of episodic memory were significantly correlated with Aβ burden, but regression analyses revealed a strong and selective association between story recall and Aβ over and beyond the effects of age, education, global cognition, hippocampal volume, or other memory tests. Analyses of sensitivity and specificity of memory measures to detect high versus low Aβ scans suggested that word-list recall performed better when high sensitivity was preferred, whereas story recall performed better when high specificity was preferred. In conclusion, a measure of story recall may increase the confidence in making a diagnosis of MCI due to AD in clinical settings. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/11575 | DOI: | 10.3233/JAD-2012-121315 | Journal: | Journal of Alzheimer's disease : JAD | URL: | https://pubmed.ncbi.nlm.nih.gov/23011220 | Type: | Journal Article | Subjects: | Aged Aged, 80 and over Amnesia.pathology.radionuclide imaging Amyloidosis.pathology.radionuclide imaging Aniline Compounds.diagnostic use Arabidopsis Proteins Biological Markers.metabolism Cyclophilins Female Fluorine Radioisotopes.diagnostic use Humans Magnetic Resonance Imaging.methods.standards Male Memory, Episodic Middle Aged Mild Cognitive Impairment.pathology.radionuclide imaging Neuropsychological Tests.standards Positron-Emission Tomography.methods.standards Predictive Value of Tests Protozoan Proteins Regression Analysis Reproducibility of Results Sensitivity and Specificity Stilbenes.diagnostic use |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.